Product Images Exemestane

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Exemestane NDC 44278-025 by Eirgen Pharma Ltd, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

figure-1 - figure 1

figure-1 - figure 1

The text describes Figure 1, which displays data for a disease-free survival study in postmenopausal women with early breast cancer. The graph shows the proportion of patients surviving on the y-axis, measured against the duration of disease-free survival in months on the x-axis. It displays the number of patients treated with exemestane and tamoxifen and the number of events observed. The HR and P values are also provided, indicating a significant difference in survival rates between the two treatments.*

figure-2 - figure 2

figure-2 - figure 2

This text is a figure caption related to a study on postmenopausal women with advanced breast cancer. It shows the time to tumor progression in women whose disease had progressed after Tamoxifen therapy. The figure displays the number of PDs (progressive diseases) and patients for two different treatments (Exemestane and Megestrol Acetate) over a period of weeks. No further information is available for interpretation.*

label - label

label - label

Each tablet of this medication contains 25 mg of exemestane. It is manufactured by EirGen Pharma Ltd in Waterford, Ireland and is a product of Taiwan. The medication is distributed in the USA by Alvogen, Inc. located in Pine Brook, NJ. The NDC number for this medication is 47781-108-30. The medication is only available through prescription and has a recommended dosage as specified in the prescribing information. The medication should be stored at a temperature between 15° to 30°C (59° to 86°F). The medication comes in a pack of 30 tablets and should be dispensed by a pharmacist with the attached patient information leaflet.*

structure - structure

structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.